Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Exclusive-Oracle to win unconditional EU nod for $28.3 billion Cerner deal -sources

Published 05/24/2022, 10:01 AM
Updated 05/24/2022, 10:36 AM
© Reuters. FILE PHOTO: The company logo for Oracle Corp. is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., September 18, 2019. REUTERS/Brendan McDermid

By Foo Yun Chee

BRUSSELS (Reuters) - U.S. business software maker Oracle Corp (NYSE:ORCL) is set to gain unconditional EU antitrust clearance for its $28.3 billion acquisition of U.S. healthcare IT company Cerner Corp (NASDAQ:CERN), three people familiar with the matter said on Tuesday.

Oracle announced the deal, its biggest ever, in December last year. It will give it access to a trove of data and could attract more healthcare clients to its cloud platform.

Cerner's data can help Oracle train and improve the software maker's artificial intelligence-based cloud services. The company, whose software traditionally ran in its customers' data centers, has started shifting its service to cloud computing providers.

The European Commission, which is scheduled to decide on the deal by June 1, and Oracle declined to comment.

Tech giants such as Microsoft Corp (NASDAQ:MSFT). have ramped up investments in the healthcare sector, spurred by demand for cloud-based solutions during the pandemic.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.